| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |